A recent legal change in Vietnam is set to unlock £250 million in pharmaceutical exports for UK companies over the next five years. This move, part of an ongoing effort to strengthen trade relations, makes it easier for British pharmaceutical businesses to sell their products in Vietnam.
Previously, UK-made medicines faced significant barriers in the Vietnamese market, including complex registration processes. Under the new law, Vietnam now recognises approvals from trusted international regulators, such as the UK’s Medicines and Healthcare products Regulatory Agency (MHRA). This streamlines the registration of medicines and vaccines, saving time and reducing costs for British pharmaceutical firms.
The changes align with broader trade efforts to deepen ties with fast-growing economies in Asia, including Vietnam. The UK government continues to focus on securing trade deals that support key industries like healthcare, finance, and renewable energy. The removal of pharmaceutical barriers is one of several steps being taken to create new commercial opportunities for UK businesses in the region.
This shift not only improves access to Vietnam’s market but also reflects the UK’s broader strategy of enhancing global trade relations. The Vietnamese market, with its growing economy and increasing demand for healthcare products, offers significant potential for British companies.
